sur Fresenius SE & Co. KGaA (ETR:FRE)
Fresenius Proposes 5% Dividend Increase Amid Strong 2025 Performance
During its 2026 Annual General Meeting, Fresenius SE & Co. KGaA showcased a robust performance for 2025, highlighting its strategic advancements. The healthcare group's success is driven by the #FutureFresenius strategy, particularly the "Rejuvenate" phase, aimed at enhancing innovation and resilience. A proposed 5% dividend increase to €1.05 per share reflects shareholder trust and financial strength.
Despite geopolitical uncertainties, Fresenius maintained financial flexibility and strategic focus. CEO Michael Sen noted the company's achievements, emphasizing balance sheet improvements and sustained investment in innovation. Notably, the company's digitalization efforts include a partnership with SAP to develop an AI-driven healthcare ecosystem.
Research initiatives also progressed, with Fresenius investing over €600 million in R&D annually, impacting areas like biosimilars and medical technology. Through strategic collaboration and innovation, Fresenius reinforces its commitment to future healthcare advancements.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Fresenius SE & Co. KGaA